申请人:Sanwa Kagaku Kenkyusho Co., Ltd
公开号:EP2447265A1
公开(公告)日:2012-05-02
The object of the present invention is to provide a compound having a glucokinase-activating effect.
A pharmaceutical composition comprising a compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient:
wherein
X means a nitrogen atom or CR6 wherein R6 means a hydrogen atom or a halogen atom;
R1 means a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group or a C1-C6 alkylthio group;
R2 means a hydrogen atom or a fluorine atom;
R3 means a hydrogen atom or a C1-C6 alkyl group; and
one of R4 and R5 means a hydrogen atom or a C1-C6 alkyl group, and the other means a C1-C6 alkylenecarboxylic acid, a C1-C6 alkylsulfonyl group, a C1-C6 alkylcarbonyl group, or CONH2.
本发明的目的是提供一种具有葡萄糖激酶激活作用的化合物。
一种药物组合物,其活性成分包括通式(I)代表的化合物或其药学上可接受的盐:
其中
X 指氮原子或 CR6,其中 R6 指氢原子或卤素原子;
R1 指氢原子、C1-C6 烷基、C1-C6 烷氧基或 C1-C6 烷硫基;
R2 指氢原子或氟原子
R3 指氢原子或 C1-C6 烷基;以及
R4 和 R5 中的一个指氢原子或 C1-C6 烷基,另一个指 C1-C6 烷烯羧酸、C1-C6 烷基磺酰基、C1-C6 烷基羰基或 CONH2。